Jammu and Kashmir sanctioned Rs 800 crore for vital health projects

Published On 2019-11-23 07:54 GMT   |   Update On 2019-11-23 07:54 GMT

New Delhi: The Centre has released Rs 836.64 crore out of the sanctioned allocation of Rs 900 crore under a financial assistance programme for vital health projects in Jammu and Kashmir, an official spokesperson said on November 22.

Out of the total 144 ongoing and new health projects approved under the Prime Minister's Development Package (PMDP), 48 projects have been completed and will be made functional soon, the spokesperson said. The information was given at a meeting chaired by Financial Commissioner, Health and Medical Education, Atal Dulloo in Srinagar on Thursday to review the works being undertaken under PMDP in the health sector, the spokesperson said.

Read Also: Odisha CM launches health projects worth Rs 400 crore for district hospitals

During the meeting, it was informed that a target has been set to complete the rest of the 96 projects by the next financial year 2020-21, the spokesperson said. The Financial Commissioner directed the executing agencies to ensure that all these projects are completed within the set deadline, the spokesman said. Dulloo said the projects being undertaken in district hospitals of Anantnag, Baramulla, Shopian, Reasi, Kishtwar, Kulgam, Ganderbal, Sub-district hospital Sopore to launch Diplomate in National Board (DNB) courses should be given top priority and completed shortly.

Read Also: Odisha cabinet enhances budgetary allocation of three health projects

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News